Related Experiment Video

Updated: Jul 4, 2026

Coculture Assays to Study Macrophage and Microglia Stimulation of Glioblastoma Invasion
09:23

Coculture Assays to Study Macrophage and Microglia Stimulation of Glioblastoma Invasion

Published on: October 20, 2016

Cucurbitacin B markedly inhibits growth and rapidly affects the cytoskeleton in glioblastoma multiforme

Dong Yin1, Naoki Wakimoto, Hongtao Xing

  • 1Division of Hematology/Oncology, Cedars-Sinai Medical Center, UCLA School of Medicine, Los Angeles, CA 90048, USA. dong.yin@cshs.org

International Journal of Cancer
|June 19, 2008
PubMed

Insights

Cucurbitacin B significantly inhibits Glioblastoma Multiforme (GBM) growth by disrupting cell structure and the JNK pathway. Further clinical trials are recommended for this promising GBM treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Glioblastoma Multiforme (GBM) is a highly aggressive and frequently fatal adult brain tumor with a poor prognosis.
  • Current treatments for GBM have limited efficacy, necessitating the exploration of novel therapeutic agents.

Purpose of the Study:

  • To investigate the anti-proliferative effects of Cucurbitacin B on human Glioblastoma Multiforme (GBM) cell lines.
  • To elucidate the underlying mechanisms of Cucurbitacin B's action on GBM cells, including its impact on cell cycle, cytoskeleton, and signaling pathways.

Main Methods:

  • Dose-response studies and soft-gel assays were used to determine the efficacy of Cucurbitacin B against GBM cell growth and clonogenicity.
  • Flow cytometry (FACS) analysis was employed to assess cell cycle arrest.
  • Immunofluorescence microscopy was utilized to observe changes in cell morphology and cytoskeletal components (actin and microtubules).
  • Western blot analysis was performed to evaluate the activation of key signaling proteins (p38, JNK, JUN).

Main Results:

  • Cucurbitacin B demonstrated potent dose-dependent inhibition of GBM cell proliferation, with significant effects at nanomolar concentrations.
  • The compound induced G2/M cell cycle arrest and caused rapid, profound alterations in GBM cell morphology, including rounding and loss of pseudopodia.
  • Disruption of actin and microtubules, along with multinucleation, were observed following Cucurbitacin B treatment.
  • Cucurbitacin B treatment led to increased phosphorylation of p38, JNK, and JUN proteins, indicating activation of these stress-related signaling pathways.
  • Inhibition of the JNK pathway using SP600125 partially blocked the morphological changes induced by Cucurbitacin B.

Conclusions:

  • Cucurbitacin B exhibits significant anti-proliferative activity against Glioblastoma Multiforme cells.
  • The mechanism of action involves disruption of the cytoskeleton and modulation of the JNK signaling pathway.
  • These findings support the potential of Cucurbitacin B as a therapeutic agent for GBM and warrant further clinical investigation.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...